Wednesday, July 29th | 15 Av 5786

Subscribe
November 11, 2021 10:51 am

Israel Approves COVID-19 Vaccination for 5-11-Year-Olds

×

Error: Contact form not found.

avatar by JNS.org

A staff member hands a face mask to a boy as students return to school after the summer break, less than a month into a coronavirus disease (COVID-19) vaccine booster drive, at Arazim Elementary School in Tel Aviv, Israel September 1, 2021. REUTERS/Amir Cohen

JNS.org – Israel has approved coronavirus vaccination for children aged 5 to 11, the Health Ministry announced in a press conference on Wednesday night.

The nearly unanimous vote—73 in favor and two against—was reached by the Pandemic Response Team and the Advisory Committee on Vaccines.

According to the ministry, of the 73 experts who voted to approve the move, 67 supported recommending that young children get inoculated, and six said they merely allowed them to do so.

The decision comes after the US Food and Drug Administration and Centers for Disease Control and Prevention approved last week the Pfizer BioNTech vaccine for 5-11-year-olds.

At the end of August, Israel was the first country to extend eligibility for a third dose of the COVID-19 vaccine to all citizens aged 12 and above. The United States followed suit several weeks later, after chief US medical adviser Dr. Anthony Fauci announced that data from Israeli booster shots would clarify the level of risk involved in administering them to citizens under the age of 65.

As Israel began a national drill on Thursday to test the country’s preparedness for the outbreak of a new, more lethal variant COVID-19, Israeli Prime Minister Naftali Bennett said that although Israel is “is in an excellent situation” where managing the virus is concerned, “we are not closing up shop.”

To safeguard the public while maintaining the flow of normal life, he stressed, “we must continue to closely monitor the situation and prepare for any scenario.”

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.